Affordable Access

Joint National Committee VI: individualized versus indiscriminate therapy for hypertension.

Authors
  • Tifft, C P
Type
Published Article
Journal
Current hypertension reports
Publication Date
Jun 01, 2000
Volume
2
Issue
3
Pages
243–246
Identifiers
PMID: 10981156
Source
Medline
License
Unknown

Abstract

The treatment of hypertension has progressed from a few nontoxic choices to the close to 60 individual drugs listed in the recommendations of the Sixth Report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Many combination drugs are also listed for use. The JNC documents have suggested initial therapy with diuretic or beta-blocker since 1993. Practitioners have followed these suggestions or not followed them on the basis of their personal bias. Since the 1997 JNC VI report, several studies that seem to support an individualistic approach to treatment have been reported. This is an exciting time in hypertension research. Clinicians who treat this common disorder will continue to line up as indiscriminate or individualistic prescribers, depending on their interpretation of the available data. We expect the hypertensive patient to be the winner of this increased attention.

Report this publication

Statistics

Seen <100 times